FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289170342> ?p ?o ?g. }

• W4289170342 abstract "Background Immune checkpoint inhibitors (ICIs) is the main treatment option for patients with metastatic renal cell carcinoma (mRCC); however, significant heterogeneity in response is commonly observed. This study aimed to evaluate the ability of C-reactive protein (CRP) to predict overall survival (OS) and progression-free survival (PFS) in patients with mRCC treated with immunotherapy. Patients and Methods Data from patients with mRCC treated with atezolizumab plus bevacizumab in the IMmotion150 and IMmotion151 trials were pooled. Cox proportional regression was used to model prognostic associations. The relative importance of CRP against International Metastatic RCC Database Consortium (IMDC) factors was confirmed using machine learning. Results CRPs were available from 527 patients (mean[range] CRP, 6.3[0.21–340]mg/L). Elevated CRP was significantly associated with worse OS (HR[95%CI], 1.71[1.54–1.90], p&lt;0.001) and PFS (1.27[1.18–1.35], p&lt;0.001). CRP was the most prognostic factor for survival within the available clinicopathological data. The prognostic performance of CRP was superior to IMDC model for OS (CRP c=0.76, IMDC c=0.67, p&lt;0.001) and PFS (CRP OS c=0.62, IMDC c=0.59, p=0.03). Predicted 2-year OS probabilities for patients with CRP values of 0.5, 5, 40, and 150 mg/L were 96%, 73%, 42%, and 23%, respectively. Conclusions CRP is a powerful prognostic marker for survival, and its prognostic value was superior to the IMDC risk model. This study highlights that CRP could be implemented as stratification factor for mRCC immunotherapy trials and potentially as an easy-to-use prognostic tool in the clinic." @default.
• W4289170342 created "2022-08-01" @default.
• W4289170342 creator A5018355869 @default.
• W4289170342 creator A5040080843 @default.
• W4289170342 creator A5060370312 @default.
• W4289170342 creator A5067594062 @default.
• W4289170342 creator A5069388405 @default.
• W4289170342 creator A5074756323 @default.
• W4289170342 creator A5089693483 @default.
• W4289170342 date "2022-08-01" @default.
• W4289170342 modified "2023-10-17" @default.
• W4289170342 title "C-reactive protein provides superior prognostic accuracy than the IMDC risk model in renal cell carcinoma treated with Atezolizumab/Bevacizumab" @default.
• W4289170342 cites W1513594981 @default.
• W4289170342 cites W1597277386 @default.
• W4289170342 cites W1895814318 @default.
• W4289170342 cites W1965037168 @default.
• W4289170342 cites W1969600215 @default.
• W4289170342 cites W1972170669 @default.
• W4289170342 cites W2013086806 @default.
• W4289170342 cites W2014229457 @default.
• W4289170342 cites W2099752220 @default.
• W4289170342 cites W2125628608 @default.
• W4289170342 cites W2129925362 @default.
• W4289170342 cites W2145235033 @default.
• W4289170342 cites W2377410957 @default.
• W4289170342 cites W2398400957 @default.
• W4289170342 cites W2582471997 @default.
• W4289170342 cites W2753599369 @default.
• W4289170342 cites W2767484432 @default.
• W4289170342 cites W2805302875 @default.
• W4289170342 cites W2883708222 @default.
• W4289170342 cites W2885876919 @default.
• W4289170342 cites W2892325025 @default.
• W4289170342 cites W2943887705 @default.
• W4289170342 cites W2997651933 @default.
• W4289170342 cites W3007433178 @default.
• W4289170342 cites W3043669370 @default.
• W4289170342 cites W3049349821 @default.
• W4289170342 cites W3102708157 @default.
• W4289170342 cites W3106005610 @default.
• W4289170342 cites W3156989699 @default.
• W4289170342 doi "https://doi.org/10.3389/fonc.2022.918993" @default.
• W4289170342 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35978814" @default.
• W4289170342 hasPublicationYear "2022" @default.
• W4289170342 type Work @default.
• W4289170342 citedByCount "2" @default.
• W4289170342 countsByYear W42891703422023 @default.
• W4289170342 crossrefType "journal-article" @default.
• W4289170342 hasAuthorship W4289170342A5018355869 @default.
• W4289170342 hasAuthorship W4289170342A5040080843 @default.
• W4289170342 hasAuthorship W4289170342A5060370312 @default.
• W4289170342 hasAuthorship W4289170342A5067594062 @default.
• W4289170342 hasAuthorship W4289170342A5069388405 @default.
• W4289170342 hasAuthorship W4289170342A5074756323 @default.
• W4289170342 hasAuthorship W4289170342A5089693483 @default.
• W4289170342 hasBestOaLocation W42891703421 @default.
• W4289170342 hasConcept C121608353 @default.
• W4289170342 hasConcept C126322002 @default.
• W4289170342 hasConcept C126894567 @default.
• W4289170342 hasConcept C143998085 @default.
• W4289170342 hasConcept C2775949291 @default.
• W4289170342 hasConcept C2776694085 @default.
• W4289170342 hasConcept C2776914184 @default.
• W4289170342 hasConcept C2777472916 @default.
• W4289170342 hasConcept C2777701055 @default.
• W4289170342 hasConcept C2777802072 @default.
• W4289170342 hasConcept C2780030458 @default.
• W4289170342 hasConcept C2780739268 @default.
• W4289170342 hasConcept C2781195455 @default.
• W4289170342 hasConcept C3019894029 @default.
• W4289170342 hasConcept C50382708 @default.
• W4289170342 hasConcept C71924100 @default.
• W4289170342 hasConceptScore W4289170342C121608353 @default.
• W4289170342 hasConceptScore W4289170342C126322002 @default.
• W4289170342 hasConceptScore W4289170342C126894567 @default.
• W4289170342 hasConceptScore W4289170342C143998085 @default.
• W4289170342 hasConceptScore W4289170342C2775949291 @default.
• W4289170342 hasConceptScore W4289170342C2776694085 @default.
• W4289170342 hasConceptScore W4289170342C2776914184 @default.
• W4289170342 hasConceptScore W4289170342C2777472916 @default.
• W4289170342 hasConceptScore W4289170342C2777701055 @default.
• W4289170342 hasConceptScore W4289170342C2777802072 @default.
• W4289170342 hasConceptScore W4289170342C2780030458 @default.
• W4289170342 hasConceptScore W4289170342C2780739268 @default.
• W4289170342 hasConceptScore W4289170342C2781195455 @default.
• W4289170342 hasConceptScore W4289170342C3019894029 @default.
• W4289170342 hasConceptScore W4289170342C50382708 @default.
• W4289170342 hasConceptScore W4289170342C71924100 @default.
• W4289170342 hasFunder F4320320438 @default.
• W4289170342 hasFunder F4320334706 @default.
• W4289170342 hasLocation W42891703421 @default.
• W4289170342 hasLocation W42891703422 @default.
• W4289170342 hasLocation W42891703423 @default.
• W4289170342 hasOpenAccess W4289170342 @default.
• W4289170342 hasPrimaryLocation W42891703421 @default.
• W4289170342 hasRelatedWork W2171714209 @default.
• W4289170342 hasRelatedWork W2413916090 @default.
• W4289170342 hasRelatedWork W2748547721 @default.
• W4289170342 hasRelatedWork W2766342472 @default.
• W4289170342 hasRelatedWork W2887267288 @default.

• next